Hers vs Maximus: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hers beats Maximus overall, scoring 7.3/10 vs 7.1/10. Hers is more affordable at $199/mo vs $300/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea.

A side-by-side comparison of Hers and Maximus covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Maximus

#46 of 48

7.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Feature	Hers	Maximus
Our Score	7.3/10	7.1/10
Starting Price	$199/mo	$300/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand	Men who want GLP-1 alongside testosterone or other men's health protocols
Ranking	#35	#46

Pros & Cons Compared

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Maximus

Pros

+Lowest entry price in the market — $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
+GLP-1 microdosing available for BMI as low as 22 — the only platform serving patients below standard obesity criteria
+Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
+Free expedited shipping on all medication orders

Cons

−Deceptive pricing structure — $99.99/mo is intro only, standard dosing is $299.99/mo with separate $28-35 consultation fees and $199-349/yr lab costs
−Refuses to disclose compounding pharmacy partners — a transparency red flag for a healthcare platform
−Prices increase as dose escalates on bulk plans — unpredictable total cost over time

Our Verdict

Hers edges out Maximus with a score of 7.3/10 vs 7.1/10. If budget is your priority, Hers starts at $199/mo compared to Maximus's $300/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor Maximus feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review